Bioingenium expands its portfolio by offering reagents for In Vitro Diagnostic

June 30, 2017

Bioingenium, a Contract Research Organisation (CRO) specialising in the protein-expression, is opening a new area of business with the production of reagents for In Vitro Diagnostic. Recombinant Streptococcus pyogenes Streptolysin O (SLO) is the first product available.

Streptolysin O is a membrane-damaging extracellular toxin produced by hemolytic streptococci. It is used for the diagnosis of a recent strep infection with group A Streptococcus, Antistreptolysin O (ASO) Titer.

This product is available worldwide. Bioingenium collaborates with regional suppliers to reach all the world. EastCoast Bio a US supplier of high quality antigens is one of them.

Since 2008 Bioingenium offers three platforms of recombinant protein production (bacterial protein expression, mammalian protein expression and Pichia pastoris expression) and support to
scale up and develop process development in pharmaceutical, cosmetics and biotechnology companies.